Psychotropic analgesic nitrous oxide for alcoholic withdrawal states

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2007, Pages

  Gillman, Mark Alfred ^a   Lichtigfeld, F J ^b   Young, T N ^b  

^a South African Brain Research Institute   (South Africa)

^b NONE

Author keywords

Alcoholic beverages *adverse effects ; Alcoholism *complications ; Analgesics, non narcotic *therapeutic use ; Nitrous oxide *therapeutic use ; Randomized controlled trials as topic

Indexed keywords

BENZODIAZEPINE; DIAZEPAM; NITROUS OXIDE; OXAZEPAM; OXYGEN; PENTOBARBITAL;

ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; ANXIETY DISORDER; CLINICAL TRIAL; DEPRESSION; DISEASE SEVERITY; DRUG EFFECT; GUILT; HUMAN; PSYCHOMOTOR ACTIVITY; REVIEW; SYMPTOMATOLOGY; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; WITHDRAWAL SYNDROME;

EID: 44949242450     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005190.pub2     Document Type: Review

References (54)

1. De Rooster 1983 {published data only} *De Rooster C. The effectiveness of nitrous oxide in the treatment of alcohol withdrawal states [Die effektiwiteit van distikstofoksied in die behandeling van die alkohol-omtrekkingsindroom]. Thesis accepted in partial fulfillment for the degree MA (Hons) Clinical Psychology, Rand Afrikaans University, Johannesburg, South Africa 1983.
2. Fey 1993 {published data only} *Fey W J. A comparative treatment study of the alcohol withdrawal syndrome: nitrous oxide and benzodiazepines. Thesis accepted in partial fulfillment BA (Hons) Clinical Psychology, University of the Witwatersrand, Johannesburg, South Africa 1993.
3. Gillman 1986a {published data only} *Gillman MA, Lichtigfeld FJ. Minimal sedation required with nitrous oxide-oxygen treatment of the alcohol withdrawal state. British Journal Psychiatry 1986;148:604-6.
4. Gillman 2004 {published data only} *Gillman MA Lichtigfeld FJ. Enlarged double-blind randomised trial of benzodiazepines against psychotropic analgesic nitrous oxide for alcohol withdrawal. Addictive Behaviors 2004;29(6):1183-7.
5. Janks 1992 {published data only} *Janks A. The use of nitrous oxide in the treatment of the alcohol withdrawal syndrome. Thesis accepted in partial fulfillment for the degree BA (Hons) Clinical Psychology, University of the Witwatersrand, Johannesburg, South Africa. 1992.
6. Alho 2002 Alho H, Methuen T, Paloheimo M, Strid N, Seppa K, Tiainen J, et al.Long-term effects of and physiological responses to nitrous oxide gas treatment during alcohol withdrawal: a double-blind, placebo-controlled trial. Alcohol: Clinical Experimental Research 2002;26(12):1816-22.
7. Alho 2003 Alho H, Metheun T, Paloheimo M, Seppä J. Nitrous oxide has no effect in the treatment of alcohol withdrawal syndrome: double-blind placebo-controlled randomized trial. Journal of Clinical Psychopharmacology 2003;23(2):211-4.
8. Daynes 1989 Daynes G. The initial management of alcoholism using oxygen and nitrous oxide: a transcultural study. International Journal of Neuroscience 1989;49(1-2):83-6.
9. Daynes 1994 Daynes G, Gillman MA. Psychotropic analgesic nitrous oxide prevents craving after withdrawal from alcohol, cannabis and tobacco. International Journal of Neuroscience 1994;76(1-2):13-6.
10. Gillman 1985 Gillman MA. Nitrous oxide as an opioid agonist: some experimental and clinical observations. Thesis accepted in fulfillment of the degree DSc at Potchefstroom University,Transvaal South Africa, 1985.
11. Gillman 1991 Gillman MA, Lichtigfeld FJ. Placebo and analgesic nitrous oxide for treatment of the alcohol withdrawal state. British Journal of Psychiatry 1991;159:672-5.
12. Gillman 2002 Gillman MA, Lichtigfeld FJ. Randomised double-blind trial of psychotropic analgesic nitrous oxide compared with diazepam for alcohol withdrawal state. Journal of Substance Abuse Treatment 2002;22(3):129-34.
13. Lichtigfeld 1982 Lichtigfeld FJ, Gillman MA. The treatment of alcoholic withdrawal states with oxygen and nitrous oxide. South African Medical Journal 1982;61(10):349-51.
14. Lichtigfeld 1989a Lichtigfeld FJ, Gillman MA. Analgesic nitrous oxide for alcohol withdrawal is better than placebo. International Journal of Neuroscience 1989;49(1-2):71-4.
15. Ojutkangas 1994 Ojutkangas R, Gillman MA. Psychotropic analgesic nitrous oxide for treating alcohol withdrawal in an outpatient setting. International Journal of Neuroscience 1994;76(1-2):35-9.
16. Alderson 2004 Alderson P, Green S, Higgins JPT, editors. Cochrane Reviewer's Handbook 4.2.2. The Cochrane Library Issue 1, 2004.
17. Amato 2005 Amato L, Davoli M, Ali R, Auriacombe M, Faggiano F, Farrell M, et al.Cochrane Drugs and Alcohol Group. The Cochrane database of Systematic Review 2004. John Wiley & Sons, LTD. Chichester, UK.
18. Christian 1991 Christian MK. Analgesic nitrous oxide for management of addictive withdrawal: a successful implementation in a Third World alcohol rehabilitation programme. 36th International Institute on the Prevention and Treatment of Alcoholism (Paper). Stockholm: 1991.
19. Clark 1999 Clark M, Brunick A. Handbook of nitrous oxide and oxygen sedation. St Louis: Mosby, 1999.
20. Desjarlais 1995 Desjarlais R, Eisenberg L, Good B, Kelinman A. World mental health. New York: Oxford, 1995.
21. Di Chiara 1988 Di Chiara, G Imperato A. Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and the dorsal caudate of freely moving rats. J Pharmacol Exp Ther 1988;244(3):1067-80.
22. Dorris 1993 Dorris RL, Truong V. Locomotor effects of nitrous oxide in mice: requirement of newly synthesized andmain intraneural storage pools of dopamine. J Pharm Pharmacol 1993;45(4):315-6.
23. DSM-IV 1994 Task Force on DSM-IV. Diagnostic and statistical manual of mental disorders. 4th Edition. Washington DC: American Psychiatric Association, 1994:197-199.
24. Gillman 1994b Gillman MA. Psychotropic analgesic nitrous oxide as an investigative, diagnostic and therapeutic tool. International Journal of Neuroscience 1994;76(1-2):1-3.
25. Gillman 1983 Gillman MA, Lichtigfeld FJ. Receptor hypothesis of the alcohol withdrawal state. In: PMandel, FVDeFeudis editor(s). CNS receptor- from molecular pharmacology to behaviour. Advances in biochemical psychopharmacology. Vol. 37, New York: Raven Press, 1983:405-415.
26. Gillman 1986b Gillman MA. Minireview: Analgesic (sub anesthetic) nitrous oxide interacts with the endogenous opioid system : A review of the evidence. Life Sciences 1986;39(14):l209-2l.
27. Gillman 1987 Gillman MA. Editorial. Haematological changes caused by nitrous oxide: Cause for concern?. British Journal Anaesthesiology 1987;59(2):143-6.
28. Gillman 1990 Gillman MA, Lichtigfedl FJ. Analgesic nitrous oxide for alcohol withdrawal: a critical appraisal after 10 years use. Postgraduate Medical Journal 1990;159(2-4):543-6.
29. Gillman 1992 Gillman MA. Nitrous oxide abuse in perspective. Clinical Neuropharmacology 1992;15(4):297-306.
30. Gillman 1994 Gillman MA, Lichtigfeld FJ. Opioid properties of psychotropic analgesic nitrous oxide (Laughing Gas). Perspectives in Biology and Medicine 1994;38(1):125-38.
31. Gillman 1995 Gillman MA. Nitrous oxide has a very low abuse potential. Addiction 1995;90(3):439.
32. Gillman 1997 Gillman MA, Lichtigfeld FJ. The current status of analgesic nitrous oxide for treating alcoholic withdrawal states. Suomen Lääkärillehti (Finnish Medical Journal) 1997;52:1055- 8.
33. Gillman 1998 Gillman MA, Lichtigfeld FJ. Clinical role and mechanisms of action of analgesic nitrous oxide. International Journal of Neuroscience 1998;93(1-2):55-62.
34. Gillman 2006 Gillman MA, Lichtigfeld FJ. New Topics in Substance Abuse Treatment. New York: Nova Science, 2006.
35. Gross 1974 Gross M, Lewis E, Hastey J. The biology of alcoholism. Vol. 3, New York: Plenum Press, 1974.
36. Herwig 1984 Herwig D, Milam S B, Jones D L. Time course of recovery following nitrous oxide administration. Anaesthesia Progress 1984;31:133-5.
37. Hobbs 1996 Hobbs WR, Rall TW, Verdoorn TA. Hyponotics and sedatives. Goodman and Gilman's The pharmacological basis of therapeutics. 9th Edition. McGraw-Hill, 1996:361-96.
38. Lichtigfeld 1983 Lichtigfeld FJ, Gillman MA. The treatment of alcoholic withdrawal states with oxygen and nitrous oxide. South African Medical Journal 1983;63:65-6.
39. Lichtigfeld 1983a Lichtigfeld FJ, Gillman MA. The treatment of alcoholic withdrawal states with oxygen and nitrous oxide. S Afr Med J 1983;63:65-6.
40. Lichtigfeld 1989 Lichtigfeld FJ, Gillman MA. The effect of placebo in the alcohol withdrawal state. Alcohol and Alcoholism 1989;24(2):109-12.
41. Lichtigfeld 1994 Lichtigfeld FJ, Gillman MA. Psychotropic analgesic nitrous oxide and neurotransmitter mechanisms involved in the alcohol withdrawal state. International Journal of Neuroscience 1994;76(1-2):17-33.
42. Lichtigfeld 1996 Lichtigfeld FJ, Gillman MA. Role of dopamine mesolimbic system in opioid action of psychotropic analgesic nitrous oxide (PAN) in alcohol and drug withdrawal. Clinical Neuropharmacology 1996;19(3):246-50.
43. Madden 1979 Madden JS. A Guide to Alcohol and Drug Dependence. Bristol: John Wright, 1979.
44. Moyes 1979 Moyes D, Cleaton-Jones D, Leliot J. Evaluation of driving skills after brief exposure to nitrous oxide. South African Medical Journal 1979;56:1000-2.
45. Myers 2003 Myers B, Siegfried N, Parry CDH. Over-the-counter and prescription medicine misuse in Cape Town - findings from specialist treatment centers. S Afr Med J 2003;93:367-70.
46. Ntais 2006 Ntais C, Pakos E, Kyzas P, Ioannidis JPA. Benzodiazepines for alcohol withdrawal. Cochrane Database of Systematic Reviews 2006, Issue 1.Art. No.: CD005063. DOI:10.1002/14651858.CD005063. pub2.
47. O'Brien 1996 O'Brein CP. Drug addiction and drug abuse. Goodman and Gillman's The pharamcological basis of therapeutics. 9th Edition. New York: McGraw-Hill, 1996:557-578.
48. Ross 1993 Ross HE. Benzodiazepine use and anxiolytic abuse and dependence in treated alcoholics. Addiction 1993;88(2):209-18.
49. Schatzberg 1978 Schatzberg AF, Cole JO. Benzodiazepines in depressive disorders. Archives of General Psychiarty 1978;35(11): 1359-65.
50. Shaw 1982 Shaw GK. Alcohol dependence and withdrawal. Brit Med Bull 1982;38(1):99-102.
51. Spanagel 1992 Spanagel R, Herz A, Shippenberg TS. Opposing tonically active endogenous opioid systems modulate mesolimbic dopmanergic pathway. Proc Nat Acad Sci USA 1992;89:2046-50.
52. Sullivan 1989 Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Brit J Addiction 1989;84(11):1353-7.
53. Whitfield 1980 Whitfield CH. Non-drug treatment of alcohol withdrawal. Current Psychiatric Research 1980;19:101-9.
54. Woods 1986 Woods SW, Charney DS, Lake J, Goodman WK, Redmond DE, Heninger DR. Carbon dioxide sensitivity in panic anxiety. Ventilatory and anxiogenic response to carbon dioxide in healthy subjects and patients with panic anxiety disorder before and after alprazolam treatment. Archives of General Psychiatry 1986;43(9):900-9.